Ivan Diaz
Overview
Explore the profile of Ivan Diaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
1892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz I, Geiger M, McKinley R
J Mach Learn Biomed Imaging
. 2024 Dec;
2(May 2024):834-855.
PMID: 39655282
Convolutional neural networks (CNNs) allow for parameter sharing and translational equivariance by using convolutional kernels in their linear layers. By restricting these kernels to be SO(3)-steerable, CNNs can further improve...
2.
Schomaker M, Denti P, Bienczak A, Burger D, Diaz I, Gibb D, et al.
Pharmacoepidemiol Drug Saf
. 2024 Dec;
33(12):e70051.
PMID: 39627164
Background: Determining a therapeutic window for maintaining antiretroviral drug concentrations within an appropriate range is required for identifying effective dosing regimens. The limits of this window are typically calculated using...
3.
Schomaker M, McIlleron H, Denti P, Diaz I
Stat Med
. 2024 Oct;
43(28):5380-5400.
PMID: 39420673
There are limited options to estimate the treatment effects of variables which are continuous and measured at multiple time points, particularly if the true dose-response curve should be estimated as...
4.
Diaz I, Salido S, Nogueras M, Cobo J
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273691
The inhibition of the hLDHA (human lactate dehydrogenase A) enzyme has been demonstrated to be of great importance in the treatment of cancer and other diseases, such as primary hyperoxalurias....
5.
Hoffman K, Salazar-Barreto D, Williams N, Rudolph K, Diaz I
Epidemiology
. 2024 Aug;
35(5):667-675.
PMID: 39109818
This tutorial discusses a methodology for causal inference using longitudinal modified treatment policies. This method facilitates the mathematical formalization, identification, and estimation of many novel parameters and mathematically generalizes many...
6.
Rudolph K, Williams N, Diaz I, Forrest S, Hoffman K, Samples H, et al.
Am J Prev Med
. 2024 Jul;
67(6):878-886.
PMID: 39025248
Introduction: People with chronic pain are at increased risk of opioid misuse. Less is known about the unique risk conferred by each pain management treatment, as treatments are typically implemented...
7.
Rodriguez D, Lipez K, Stashenko E, Diaz I, Cobo J, Palma A
RSC Adv
. 2024 Jul;
14(29):20951-20965.
PMID: 38957579
In this study, an alternative and efficient one-pot three-component synthesis approach to develop a new series of ()-2-aryl-4-styrylquinazolines and ()-4-styrylquinazolines is described. According to this approach, the target compounds were...
8.
Williams N, Hoffman K, Diaz I, Rudolph K
Am J Epidemiol
. 2024 Jun;
193(12):1768-1775.
PMID: 38879744
Investigators often report estimates of the average treatment effect (ATE). While the ATE summarizes the effect of a treatment on average, it does not provide any information about the effect...
9.
Ogburn E, Sofrygin O, Diaz I, van der Laan M
J Am Stat Assoc
. 2024 May;
119(545):597-611.
PMID: 38800714
We describe semiparametric estimation and inference for causal effects using observational data from a single social network. Our asymptotic results are the first to allow for dependence of each observation...
10.
Rudolph K, Williams N, Diaz I
Biostatistics
. 2024 Apr;
25(4):997-1014.
PMID: 38576206
Mediation analysis is appealing for its ability to improve understanding of the mechanistic drivers of causal effects, but real-world data complexities challenge its successful implementation, including (i) the existence of...